These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28253371)

  • 1. Autophagy regulates UBC9 levels during viral-mediated tumorigenesis.
    Mattoscio D; Casadio C; Miccolo C; Maffini F; Raimondi A; Tacchetti C; Gheit T; Tagliabue M; Galimberti VE; De Lorenzi F; Pawlita M; Chiesa F; Ansarin M; Tommasino M; Chiocca S
    PLoS Pathog; 2017 Mar; 13(3):e1006262. PubMed ID: 28253371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV E6 proteins target Ubc9, the SUMO conjugating enzyme.
    Heaton PR; Deyrieux AF; Bian XL; Wilson VG
    Virus Res; 2011 Jun; 158(1-2):199-208. PubMed ID: 21510985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
    Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk HPV16E6 stimulates hADA3 degradation by enhancing its SUMOylation.
    Chand V; John R; Jaiswal N; Johar SS; Nag A
    Carcinogenesis; 2014 Aug; 35(8):1830-9. PubMed ID: 24795430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 can contribute to viral-induced transformation of primary human keratinocytes.
    Lathion S; Schaper J; Beard P; Raj K
    Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
    Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
    J Virol; 2024 Feb; 98(2):e0172623. PubMed ID: 38226814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of interferon signaling in human papillomavirus infection.
    Koromilas AE; Li S; Matlashewski G
    Cytokine Growth Factor Rev; 2001; 12(2-3):157-70. PubMed ID: 11325599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
    Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
    PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression.
    Dizanzo MP; Bugnon Valdano M; Basukala O; Banks L; Gardiol D
    BMC Cancer; 2022 Sep; 22(1):1015. PubMed ID: 36153517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of basal cell fate during productive and transforming HPV-16 infection is mediated by progressive E6-driven depletion of Notch.
    Kranjec C; Holleywood C; Libert D; Griffin H; Mahmood R; Isaacson E; Doorbar J
    J Pathol; 2017 Aug; 242(4):448-462. PubMed ID: 28497579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Functions of the Human Papillomavirus E6 Oncoproteins.
    Wallace NA; Galloway DA
    Annu Rev Virol; 2015 Nov; 2(1):403-23. PubMed ID: 26958922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic human papillomaviruses activate the tumor-associated lens epithelial-derived growth factor (LEDGF) gene.
    Leitz J; Reuschenbach M; Lohrey C; Honegger A; Accardi R; Tommasino M; Llano M; von Knebel Doeberitz M; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS Pathog; 2014 Mar; 10(3):e1003957. PubMed ID: 24604027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.
    Ganguly N; Parihar SP
    J Biosci; 2009 Mar; 34(1):113-23. PubMed ID: 19430123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Analysis of IL-1 Cytokine Signaling Suppression by HPV16 Oncoproteins.
    Castagnino P; Kim HW; Lam LKM; Basu D; White EA
    J Virol; 2022 Nov; 96(22):e0132622. PubMed ID: 36342298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation.
    Dust K; Carpenter M; Chen JC; Grant C; McCorrister S; Westmacott GR; Severini A
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillomavirus E6 and E7 proteins and their cellular targets.
    Wise-Draper TM; Wells SI
    Front Biosci; 2008 Jan; 13():1003-17. PubMed ID: 17981607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.